Nathan Connell: New Research on Heavy Menstrual Bleeding in Women With von Willebrand Disease
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:
“New research on heavy menstrual bleeding in women with von Willebrand disease
This open-access article in Haemophilia Journal focuses on heavy menstrual bleeding (HMB) in women with von Willebrand disease.
While VWD is the most common inherited bleeding disorder, its impact on women’s health, particularly HMB, is often underdiagnosed. This research is a crucial reminder of the importance of considering underlying bleeding disorders in women presenting with HMB.
Key takeaways from the article and related research:
- HMB is a highly prevalent symptom in women with VWD, affecting a significant majority of patients.
- The article reinforces that HMB in women with VWD can lead to complications such as iron deficiency anemia, which severely impacts a person’s quality of life.
- Diagnosis can be challenging as VWF levels can fluctuate. The article stresses the importance of proper hemostatic testing and a detailed patient history to avoid misdiagnosis.
- Effective management strategies for HMB in women with VWD are discussed, including hormonal therapies, antifibrinolytic drugs, and in some cases, VWF/FVIII concentrate.
This is a vital topic for hematologists, gynecologists, and primary care physicians to collaborate on, ensuring women receive the correct diagnosis and treatment.”
Title: Prevalence and Impact of Heavy Menstrual Bleeding in Women With von Willebrand Disease Across Age Groups: A Retrospective Study
Authors: Anna Olsson, Petra Elfvinge, Eva Zetterberg, Linda Myrin-Westesson
Read the full paper here.
Stay informed with Hemostasis Today.
-
Jun 8, 2026, 06:30Caryn Blumenfeld: Team Zakophilia and Ratner’s Runners Even Though It’s A Walk!
-
Jun 8, 2026, 06:25Cécile Jefford: The NEHA Community and the Power of Human Connection
-
Jun 8, 2026, 06:02Manoj K: How Incyte Could Help Transform Care for Patients With von Willebrand Disease
-
Jun 8, 2026, 03:05Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
-
Jun 8, 2026, 03:03Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
-
Jun 8, 2026, 02:59Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients
-
Jun 7, 2026, 22:11Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity
-
Jun 7, 2026, 19:35Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
-
Jun 7, 2026, 18:25Nita Radhakrishnan: Every Child Cured Is a Reminder of What Can Be Achieved When We Work Together